Related Experiment Video
Updated: Oct 3, 2025

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Dexmedetomidine improves success of paediatric MRI sedation
Thomas J Jackson1,2, Deborah Dawes3, Shaista Ahmad4
1Paediatrics, North Middlesex University Hospital, London, UK thomas.jackson4@nhs.net.
Insights
Intranasal dexmedetomidine significantly improves sedation success rates for pediatric MRI scans. This approach is more effective than current National Institute for Health and Care Excellence guidelines and oral midazolam.
Area of Science:
- Pediatric imaging and anesthesia
- Pharmacology of sedation agents
Background:
- Sedation is often required for pediatric MRI scans.
- Current sedation protocols have variable success rates.
Purpose of the Study:
- To compare the efficacy of different sedation strategies for pediatric MRI.
- To evaluate intranasal dexmedetomidine as a primary and rescue sedation agent.
Main Methods:
- Retrospective audit of 74 pediatric patients undergoing 85 MRI scans.
- Comparison of three sedation approaches: NICE guidance, chloral hydrate alone, and intranasal dexmedetomidine-based regimens.
- Analysis of sedation success rates and side effect profiles.
Main Results:
- Intranasal dexmedetomidine achieved significantly higher success rates (81%) compared to NICE guidance (52%, p=0.017).
- Dexmedetomidine was more effective than oral midazolam (76% vs 33%, p=0.026).
- The side effect profile of dexmedetomidine was consistent with larger studies.
Conclusions:
- Intranasal dexmedetomidine is an effective alternative for pediatric MRI sedation.
- It offers improved success rates compared to existing methods, including oral midazolam.
- Dexmedetomidine can also serve as a rescue medication when initial sedation fails.
Objective:
To improve success rates of children requiring sedation for MRI.
Methods:
Audits of sedation success for children attending planned MRI using three different approaches: (1) National Institute for Health and Care Excellence (NICE) guidance (chloral hydrate if <15 kg and oral midazolam if ≥15 kg), (2) Chloral hydrate for all patients, (3) Chloral hydrate±intranasal dexmedetomidine if <15 kg and intranasal dexmedetomidine alone if ≥15 kg.
Results:
74 patients had 85 MRI scan attempts. Overall success rates were significantly higher when using intranasal dexmedetomidine compared with following NICE guidance (81% vs 52% p=0.017). Dexmedetomidine performed better than oral midazolam for the same indication (76% vs 33% p=0.026). The side effect profile for dexmedetomidine was as reported in larger studies.
Conclusions:
Intranasal dexmedetomidine is an effective alternative to oral midazolam for sedation for MRI and as a rescue medication where chloral hydrate has been ineffective.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System IV: CMRI
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Skeletal Muscle Relaxants: Therapeutic Uses
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

![Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F67458.jpg&w=3840&q=50)